Nanoparticles could be cluster bombs for lung cancer
A drug delivery system based on nanotechnology could improve the
treatment of cancers of the lung, according to a new report.
Tackling side effects with drug delivery
A small US company has developed an encapsulation technology for
pharmaceuticals that promises to overcome a major healthcare
problem - deaths and illness caused by aspirin and other
non-steroidal anti-inflammatory drugs (NSAIDs).
New venture to tackle oral film delivery
MonoSol has set up a new venture, called MonoSolRx, aimed at
developing oral film strip technologies for use in the delivery of
AstraZeneca extends oral profiling deal
AstraZeneca has extended an agreement with UK-based Cyprotex to
bulk screen whether its drug candidates for suitable for oral
Elan raises €55m in new sell-off
Irish pharmaceutical group Elan has raised around $70 million
(€55m) from four new deals, including the sale of formulation and
Bespak recovery on track
Bespak has reported declining sales and profits at its half-yearly
results, but said the figures showed that a recovery plan was on
Swallowing an underestimated problem in adults, says survey
A survey has found that difficulties in swallowing pills is
widespread among adults, but is rarely discussed with doctors and
can prevent some people from taking their medicine. The findings
suggest that pharmaceutical companies should...
CIMA ditches aaiPharma for Cephalon
Cephalon is to acquire CIMA Laboratories, best known for its
dissolve-on-the-tongue tablet technology, for $515 million (€449m)
Pump makers under pressure
Escalating inflation rates and price pressures are hitting the
profit margins of positive displacement pump manufacturers and
inhibiting R&D, says new study.
Safety syringes booming
The market for retractable syringes designed to prevent needlestick
injuries is set for explosive growth and could expand nearly
seven-fold by 2006, according to a new report.
Flamel to raise $62m in share offering
France's Flamel Technologies has started a drive to raise funds in
the USA via a placement of shares aimed at raising $62.1 million,
to be spent on advancing its drug delivery technologies.
Smiths out, says Medisys
Medisys has terminated its marketing agreement with Smiths Group
for the Futura safety syringe after last week's falling-out which
followed a further delay in the product's launch.
Swiss expansion for Ferring
Ferring Pharmaceuticals has unveiled plans to invest €90 million in
a state-of-the-art production site in Saint-Prex in Switzerland.
Profile on the verge of take-off?
Profile Therapeutics has reported strong growth in sales and a
reduced operating loss for the year-ended June 30, and expects this
trend to continue as its R&D efforts in improved nebuliser
technologies come to fruition.
Interims confirm turnaround at Flamel
French drug delivery specialist Flamel posts a healthy rise in
revenues in the second quarter, boosted by milestone payments from
GSK and Servier.